A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

计划入组 750 人 · 首次发布于 2025 年 10 月 9 日

Radiofrequency Ablation of Malignant Pulmonary Nodules

计划入组 500 人 · 首次发布于 2015 年 12 月 15 日

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

计划入组 1,750 人 · 首次发布于 2023 年 7 月 7 日

multi system atrophy program

Methylphenidate transdermal (Nutriband)

Buprenorphine transdermal (Nutriband)

VENUS MEDTECH-B

Hong Kong, China

Stereotaxis

United States

PULMONARY HOMECARE

United States

Pulnovo Medical Enrolls First U.S. Patients in PULSE-LHD IDE Trial of PADN for Pulmonary Hypertension Associated with Left Heart Disease

Pulnovo Medical Secures $100M Series C Funding to Advance Pulmonary Hypertension Treatment

Pulnovo Medical Raises $100M to Advance Pulmonary Hypertension Treatment Development